Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-16-142261

Pres. & Chief Executive Offic sold 1,972 shares at $2.89 ($5,699)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BRISTOW MICHAEL R Pres. & Chief Executive Offic 2016-09-20 Sale −1,972 $2.89 $5,699 42,638 D: show line 1 in the form
Open-market sales · 1,972 sh · avg $2.89 · $5,699
Loading xslF345X03/doc4.xml…